VXRT

Vaxart, Inc.

Biological Products, (No Diagnostic Substances)OTCNon-accelerated filer<br>Smaller reporting company

Total Trades

8

Buys

7

Sells

1

Largest Trade

$15K–$50K

Insiders

5

Institutional Funds

5

Inst. Value

$15K–$50K

Activist Filings

9

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Watson W. MarkDirectorBUY$1K–$15K20K$0.41Dec 5, 2025
HERON ELAINE JDirectorBUY$15K–$50K40K$0.40Nov 21, 2025
Watson W. MarkDirectorBUY$1K–$15K10K$0.41Aug 1, 2025
Lo StevenPresidentBUY$15K–$50K100K$0.49May 19, 2025
Watson W. MarkDirectorBUY$1K–$15K20K$0.68Jun 20, 2024
Watson W. MarkDirectorBUY$15K–$50K20K$0.76Dec 28, 2022
Yedid Robert A.DirectorSELL$1K–$15K2K$6.01Oct 7, 2022
Ahmad FuadInterim CFOBUY$15K–$50K5K$3.22Jun 23, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 5 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Sio Capital Management, LLC

SC 13G · Apr 8, 2025

2.5%

5.6M shares

Sio Capital Management, LLC

SC 13G · Feb 10, 2025

5.1%

11.5M shares

The Vanguard Group - 23-1945930

SC 13G/A · Feb 13, 2024

4.6%

7.0M shares

RA Capital Management, L.P.

SC 13G · Jan 19, 2024

9.1%

15.4M shares

BlackRock, Inc.

SC 13G/A · Jul 7, 2023

1.3%

1.9M shares

BlackRock, Inc.

SC 13G/A · Jan 31, 2023

6.7%

8.9M shares

View on Google Finance →